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The Semanticscience Integrated Ontology (SIO) is an ontology to facilitate biomedical knowledge discovery.
SIO features a simple upper level comprised of essential types and relations for the rich description of arbitrary
(real, hypothesized, virtual, fictional) objects, processes and their attributes. SIO specifies simple design patterns
to describe and associate qualities, capabilities, functions, quantities, and informational entities including textual,
geometrical, and mathematical entities, and provides specific extensions in the domains of chemistry, biology,
biochemistry, and bioinformatics. SIO provides an ontological foundation for the Bio2RDF linked data for the life
sciences project and is used for semantic integration and discovery for SADI-based semantic web services. SIO is
freely available to all users under a creative commons by attribution license. See website for further information:
http://sio.semanticscience.org.Background
Biomedical research is poised to enter an era of unprece-
dented large scale data analysis powered by hundreds of
public biological databases and hundreds of millions of
patient records. There is a real and urgent need to explore
effective methods for biomedical data integration and
knowledge management [1,2]. Semantic-based techno-
logies, such as ontologies, offer a proven method to
exploit expert-based knowledge in the analysis of
large datasets through terminological reasoning such as
correspondence, classification, query answering and
consistency checking [3-5].
The Semantic Web effort, as pursued under the auspices
of the World Wide Web Consortium (W3C), provides a
set of standards to facilitate the representation, publica-
tion, linking, querying and discovery of heterogeneous
knowledge using web infrastructure [6]. In particular,
the Resource Description Framework (RDF) [7] enables
triple-based assertions about resources using web-friendly
identifiers, RDF Schema (RDFS) [8] offers vocabulary to
create terminological hierarchies, and the Web Ontology* Correspondence: michel.dumontier@stanford.edu
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distribution, and reproduction in any mediumLanguage (OWL) [9] assists in the construction and inter-
pretation of ontologies as sophisticated logic-based ex-
pressions to more precisely capture the meaning of types
and relations between entities. With dozens of high value
datasets now available in RDF and hundreds of biological
ontologies expressed using OWL, there is a tantalizing
opportunity to use these resources in knowledge discov-
ery. Biomedical researchers have made use of Semantic
Web technologies to uncover curation errors in systems
biology models [10], find putative disease-causing genes
[11], identify aberrant pathways [12], and uncover alterna-
tive drug therapies based on mechanism of action [13],
among others [14]. These knowledge-based applications
use automated reasoning over a coherent knowledge base
often crafted from multiple and different underlying rep-
resentations. Ontology-design patterns offer a simple way
to guide users towards a uniform representation of know-
ledge [15-17].
With the goal of facilitating knowledge discovery
through simple, but effective ontology-based data inte-
gration, we developed the Semanticscience Integrated
Ontology (SIO). SIO offers classes and relations to describe
and relate objects, processes and their attributes with spe-
cific extensions in the biomedical domain. Its relations
cover aspects of spatial and temporal qualitative reasoningtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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topology; participation and agency, linguistic and symbolic
representation, as well as comparative and other informa-
tion-oriented relations. Using straightforward mappings,
we report on the substantial benefits afforded by SIO in
the retrieval of RDF-based linked data and automatic
composition of OWL-described semantic web services.
Although SIO development is driven by needs in the
biomedical domain, we show that SIO can be applied to a
broader set of domains.
This paper is organized as follows: we first describe
the current state of the SIO OWL implementation, and
then we describe ontological foundations and essential
relations in mereotopology, participation and reference.
We then present three uses of SIO in knowledge repre-
sentation and outline its use in the integration of data
and web services. We finish with a brief comparison
with related work. As a matter of convention, we use
‘single quotes’ to indicate labels, boldface to indicate
classes, and italics to indicate relations.
The semanticscience integrated ontology
As of November 2013, SIO (v1.0) is implemented as an
OWL-DL ontology (SRIQ(D) expressivity) that comprises
of 1396 classes, 203 object properties, 1 datatype property,Figure 1 Selected portions of (A) class and (B) object property hierarc8 annotation properties, 7272 axioms, 1747 subClassOf
axioms, 43 equivalentClass axioms, and 209 subProper-
tyOf axioms. English labels are provided using the rdfs:
label annotation property while human readable, English
language definitions are provided using the Dublin Core
(dc:) Metadata term dc:description. The ontology has max-
imum depth of 41 subclasses while the average number of
children is 2. Figure 1 shows a slice of the class and
object-property hierarchies where ‘entity’ is the top level
class and ‘is related to’ is the top level object property.
Ontological foundation
SIO adheres to a three-dimensional worldview that is
familiar to most scientists – one that distinguishes be-
tween processes and the objects that participate in them.
An ‘object’ is an ‘entity’ that occupies space and is fully
identifiable by its characteristics at any moment in time
in which it exists. A ‘process’ is an ‘entity’ that unfolds
in time and has temporal parts. While an entity ‘exists
at’ and ‘is located in’ some space and time (Figure 2B),
these need not be real space or real time, but may instead
occur in a hypothetical (propositional), virtual (electronic),
or fictional (creative work) setting. A ‘quality’ (intrinsic
attribute), ‘capability’ (action specification) or ‘role’ (be-
havior, right and obligation) may exist at some time in thehies in SIO.
Figure 2 Key objects and relations in SIO. (A) Key SIO entities are objects, processes and their attributes (qualities, capabilities, roles,
measurement values). Processes have objects as participants and may realize specific roles and capabilities. (B) Spatial and temporal qualification
of SIO entities is captured through a set of relations (is located in, exists at) and sub-relations (e.g. is contained in, is part of, measured at), while
(C) information in the form of literals (string, numbers, dates) are captured as instances of information content entities which are associated with
their specific objects or processes.
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which it plays a critical role (Figure 2A). The value of
an informational entity such as a ‘measurement value’
(‘quantity’ or ‘position’) is represented as a literal - string,
number (integer, float, double), boolean or date - using
the ‘has value’ data property (Figure 2C).
Mereotopology
SIO offers a number of mereotopological relations that
can be used to describe one or more entities in terms of
their spatial organization (Figure 3A). The parent relation
'is located of ' is a transitive relation that holds true if the
spatial or temporal region of one entity fully overlaps with
the spatial or temporal region of another entity. 'has part'
is a relation that is reflexive in the sense that the whole is
a part of itself, and is also transitive in that a component
of a part is also a component of the whole. Therefore, a
query on the ‘has part’ relation will return the whole as an
answer. 'has proper part' is an irreflexive and asymmetric
relation that ensures that the whole is different from
and not one of its proper parts. 'has direct part' enables
users to quantify the number of parts (via a cardinalityFigure 3 Relation hierarchies for (A) mereotopological relations, (B) prestriction) at a desired type granularity, which is not
otherwise possible in OWL over the transitive ‘has part’
relation. 'has component part' may be used to indicate that
the part is intrinsic to the whole, and that the removal of
the part changes the identity of the whole, with the caveat
that there is no logic in OWL to directly infer this. 'con-
tains' is a transitive relation in which the 3D spatial region
occupied by entity A fully overlaps with the spatial region
occupied by entity B, but it is not the case that A has B as
a part. 'surrounds' is a relation that can be used to indicate
that A 'contains' B and either A 'is adjacent to' B or A 'is
directly connected to' B.
The next set of mereotopological relations allows one to
specify how the parts are positioned to one another. 'is con-
nected to' is a symmetric, transitive relation that specifies
that components either directly share a boundary (they are
directly connected to each other) or that they are indirectly
connected by a path of unbroken direct connections. 'is
directly connected to' is a symmetric relation that indicates
that two components share a boundary. Since this relation
is non-transitive, we can use it in statements to quantify
the number of connections from one part to other kinds ofarticipatory relations, and (C) referential relations.
Dumontier et al. Journal of Biomedical Semantics 2014, 5:14 Page 4 of 11
http://www.jbiomedsem.com/content/5/1/14parts. 'is directly before' is a relation between entities placed
on a dimensional axis in which the projection of the pos-
ition of the first entity is numerically less than the projec-
tion of the position of the second entity, and the entities
are adjacent to one another. This is useful for indicating
the spatial positioning of residues in linear biopolymers
such as proteins or nucleic acids. A domain specific rela-
tion such as ‘is covalently connected to’ then enables one to
describe the atomic connectivity within a molecule such as
methane (Figure 4).
Processes and participation
SIO provides a set of relations to describe processes in
terms of their participants and their actions (Figure 3B).
'has participant' indicates which entities participate in a
process. 'has agent' specifies entities that directly or ac-
tively participate in the process. 'has input' specifies en-
tities at the start of the process. ‘has parameter’ specifies
those variables (and their values) used in the process.
'has target' specifies entities that are modified during the
process, but retain their identity. 'has substrate' specifies
entities that are consumed (or are sufficiently changed
that they lose their canonical identity). 'has product' speci-
fies new entities formed as a result of a process. Relations
such as ‘has substrate’, ‘has target’, ‘has product’ are examples
of role-specialized relations. In SIO, more explicit role-
based assertions can be formulated by stating that the role
of an entity is realized in the process. For instance, Figure 5
shows a description of phosphorylation of an enzyme by
ATP in which substrate and product roles are realized.Figure 4 Exact description of a molecule of methane using mereotopSIO includes an OWL2 property chain [realizes o is
role of - > has participant] which enables an OWL2 DL
reasoner to infer that entities having the realized role are
also participants of the process.Referential relations
Referential relations in SIO are used to indicate what an
object refers to or the nature of the mention of one entity
by another (Figure 3C). At the top level, ‘refers to’ enables
this basic mention, while ‘references’ is a relation where
one entity mentions another, ‘describes’ is a relation where
one entity provides a detailed account of another, and ‘rep-
resents’ is a relation where one entity is a sign, symbol or
model for another. ‘describes’ is further partitioned into ‘is
about’ where one entity provides information about an-
other while ‘specifies’ contains specific information that
can be used as evaluation criteria to determine the degree
of conformance. ‘references’ is further subdivided into
‘cites’ as a relation to refer to by way of example, authority
or proof, and ‘has evidence’ which is a relation between a
proposition and something that demonstrates the truth of
the assertion. ‘has evidence’ has three sub-properties (‘is
supported by’, ‘is disputed by’, ‘is refuted by’) which can ar-
ticulate the type of evidence that one entity offers another.
Finally, ‘represents’ is subdivided into ‘denotes’ which is a
relation between an entity and what it is a sign or indica-
tion of, or what it specifically means, and ‘is model of ’
which indicates that an artifact is a model or representa-
tion of another.ological relations in equivalent class axioms.
Figure 5 Description of a process in terms of the participants and their roles.
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In this section we detail three use cases that outline how
SIO can be used to represent biomedical knowledge, sci-
entific experiments, and measurements.Biomedical knowledge
In addition to the foundational classes and relations
described above, SIO offers additional classes and re-
lations to describe elements of biomedical interest in-
cluding proteins, lipids, nucleic acids, small molecules,
genotypes, phenotypes, biochemical reactions and path-
ways (Figure 6).
For instance, we can describe an enzyme-encoding gene
as a gene that encodes a protein whose function is to
covalently modify another chemical entity in some chem-
ical reaction (Figure 7).Figure 6 Conceptual map of SIO entities and the relations
between them as it pertains to molecular biology. Rounded
boxes indicate classes. Arrows indicate relations. Overlap of one
concept on another indicates a subclass relationship (e.g. Gene is a
type of DNA region).Phenotypes arising from specific genotypes can be
expressed as attributes of an organism having a gene with
a certain nucleotide (Figure 8).Scientific experiment
In this use case, we describe the various parts and
relationships within a scientific investigation. A sci-
entific ‘experiment’ (Figure 9) is a ‘procedure’ that
aims to support, dispute or refute a well formulated
‘hypothesis’ by ‘analysis’ of ‘data’ obtained through
‘observation’ and/or ‘measurement’. Experiments usually
involve:
 the development of a research ‘plan’ which
includes, but is not limited to:
○ the formulation of a ‘hypothesis’
○ the formulation of aims and ‘objectives’
○ the formulation of a ‘study design’
 the execution of the research plan which includes,
but is not limited to:
○ the ‘selection, preparation or collection’
of a ‘sample’
○ the ‘collection of data’ through ‘observation’,
‘assay’ or ‘measurement’
○ the ‘analysis’ of ‘data’
○ the preparation of an investigational
‘report’
Figure 9 illustrates a pattern to express the relation-
ship among a research plan, study design, experiment
and its parts (e.g. sample preparation, measurement,
analysis). Temporal parts are linked to the whole using
SIO’s ‘has proper part’ relation, while temporal ordering
is achieved with SIO’s ‘precedes’ relation.
A ‘description’ provides detailed information ‘about‘
some ‘entity’ (‘object’, ‘process’ or ‘attribute’), a ‘hy-
pothesis’ is a proposed explanation of some phenomena,
and an ‘objective’ is a description of a desired outcome.
A description that ‘specifies‘ a set of actions to be exe-
cuted is an ‘action specification’ and include ‘plans’,
‘study designs’, recipes and ‘protocols’. A plan should
clearly identify (‘specify’) one or more ‘objectives’, and
Figure 7 Description of an enzyme-encoding gene.
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tributes’. A plan, like any action-based specification ‘is
manifested as’ a ‘process’. An objective ‘is realized in’ an
experiment if and only if its outcomes are fully apparent.
Data generated from the experiment may also serve as
‘evidence for’ the hypothesis, and more specifically found
to be ‘in support of ’, ‘in dispute of ’, or ‘in refutation of ’ the
hypothesis. The Ontology for Biomedical Investigations
(OBI) features more specific assays, material and data pro-
cessing techniques [18].
Measurements and measurement values
Measurement values such as quantities or spatial posi-
tions are captured as information content entities (ICE),
where the ICE is an attribute of the entity in question and
the literal value is captured using SIO’s ‘has value’ data
property. Units of measurements such as those defined by
the Unit Ontology (UO) are indicated with SIO’s ‘has unit’
object property. The following RDF/N3 example (using
the labels as URIs subset of SIO) shows how SIO captures
Rob’s mass of 74.5 kg using a measurement scale on Jan
15, 2012 at 12:03 pm EDT (Figure 10).
Applications
Semantic data integration and question answering
The Bio2RDF project uses Semantic Web technologies
to offer the largest network of linked data for the life
sciences [19]. Although the Bio2RDF approach provides
minimal syntactic and referential interoperability (using
RDF and a shared URI pattern), it does not address the
issue of semantic interoperability across its datasets.Figure 8 Description of phenotype linked to a particular genotype.Recent work [20] mapped SIO types and relations to
Bio2RDF’s dataset-specific types and relations, thereby en-
abling SIO-based queries over linked data. In that work,
resources such as DrugBank [21], the Pharmacogenomics
Knowledgebase [22] and the FDA’s National Drug Code




were mapped as subclasses of the SIO class ‘drug’.
Bio2RDF vocabulary mappings to SIO also make it pos-
sible to execute complex SPARQL queries over multiple
Bio2RDF endpoints. For example, Figure 11 shows a
SPARQL query that retrieves all the biochemical reactions
in the Bio2RDF BioModels database [23] that are involved
in the Gene Ontology (GO) term "protein catabolic
process" or one of its subclasses.
This query is possible because the BioModels type for
biochemical reaction has been mapped as a subclass of
SIO’s ‘biochemical reaction’. Similarly, the BioModels
predicate for ‘is identical to’ has been mapped as a sub-
property of SIO’s ‘is identical to’.
Semantic Web service interoperability
The Semantic Automated Discovery and Integration
(SADI) framework consists of a set of design patterns for
producing stateless Web Services that natively consume
and produce RDF data [24,25]. SADI services have been
used to classify and annotate molecules based on their
structure [26] and to uncover health information regarding
drug-drug interactions [27]. The structure of the input and
Figure 9 Diagram illustrating major entities and their relations in a scientific experiment.
Dumontier et al. Journal of Biomedical Semantics 2014, 5:14 Page 7 of 11
http://www.jbiomedsem.com/content/5/1/14output data for SADI services are formally described by an
input OWL class and an output OWL class respectively.
Nearly 800 SADI services have been created as part of the
C-BRASS (Canadian Bioinformatics Resources as Semantic
Services) project. Consider for example, the abridged input
and output descriptions for a SADI Web service [28] that
executes BLASTN on the genome of Prunus dulcis. This
service takes as an input a ‘deoxyribonucleic acid se-
quence’ and generates as output an instance of “BLASTed-
Sequence that ‘has part’ some (‘Subsequence’ that (‘is part
of ’ some (‘biopolymer sequence’)) and ‘is part of ’ some
‘BLASThit’)”. Table 1 shows the top 10 SIO classes and
relations that are directly referred to in the SADI glo-
bal service registry.Figure 10 Description of a mass measurement and value for an indivSADI services can also be orchestrated into a computa-
tional workflow by matching the outputs of one service
with the inputs of another service [25]. The SADI-aware
SHARE client decomposes a SPARQL query into an exe-
cutable workflow by matching the query components with
SADI services. SADI uses an OWL reasoner to find ap-
propriate matches between service inputs and outputs by
finding those that subsume one another. In Figure 12,
we show a SPARQL query that can be interpreted by
the SHARE client to find proteins and compounds in the
caffeine metabolism pathway (has00232). To answer this
query, the SHARE client invokes three SADI services
that wrap 2 existing BioMoby services that use SIO
predicates ‘has participant’ and ‘encodes’.idual.
Figure 11 SPARQL query that uses SIO to obtain biochemical reactions from the BioMODELS database where the reactions are
annotated with the Gene Ontology term “protein catabolic process” or one of its subclasses.
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Web (ELSEWeb) project to streamline the flow of heteroge-
neous geospatial data in order to ease the task of creating
multi-source models of species-distribution [29]. ELSEWeb
translates a family of industry standard XML geospatial
metadata (e.g., OGC WCS, FGDC, CF) into RDF that is
based on constructs defined by SIO and the Extensible Ob-
servation Ontology (OBOE) [30]. Geospatial satellite data is
automatically discovered, transformed, and integrated with
species distribution models services using the ELSEWebData
ontology. The alignment of SIO, OBOE, ELSEWebData al-
lows geospatial data to be queried and integrated with both
data from the bio and environmental communities, provid-
ing a wider spectrum of modeling potential.Table 1 Top 10 classes and relations used in SADI services
registered at sadiframework.org
Class Frequency Property Frequency
Deoxyribonucleic acid
sequence
159 Has part 289
Protein sequence 41 Is about 71
Ribonucleic acid sequence 21 Has attribute 67
Definition 2 Is attribute of 17
Name 2 Is part of 9
Sequence motif 2 Has output 9
Answer 1 Is derived from 9
Common name 1 Derives into 9
Description 1 Is similar to 9
Preferred name 1 Overlaps with 9Nanopublishing
The publication of structured research data on the inter-
net is an emerging area of interest. The nanopublication
[31] is one effort that offers an RDF framework to capture
assertions along with their provenance. Nanopublications
have been used in enabling publication of genetic data
[32] and more recently to arbitrary statements [33]. SIO is
now being used to capture protein-protein interactions
and gene-disease associations obtained through text
mining [34]. To accommodate computed associations,
we extended SIO with ‘association’ and more specific
types including ‘gene-disease association’. In Figure 13
we show a portion of a nanopublication that expresses an
association between the gene CENPJ and Seckel Syn-
drome that was obtained through text mining. SIO is used
to assert the type of association, the entities that are in the
association (identified using Bio2RDF identifiers), and the
associated p-value.
Related work
The OBO Foundry is a collaborative effort to construct
a set of orthogonal interoperable Open Biomedical
Ontologies (OBO) [35]. OBO Foundry ontologies use
the Basic Formal Ontology (BFO) as an upper level
ontology for domain independent types and the Relation
Ontology (RO) as a source of domain-independent re-
lations. The BFO is a small (36 class) ontology that is
intentionally limited by its realist philosophy to classes
with at least one known instance and whose instances
only exist in real space and time [36,37]. In contrast, SIO
simplifies the declaration and characterization of hypo-
thetical, theorized or virtual entities (simply by virtue of
Figure 12 SPARQL query to obtain proteins encoded by genes in KEGG pathways.
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to situations of interest to the health care and life sciences
including the presumed existence of underlying agents in
medical disease or the existence of entities or attributes
that are computationally predicted. SIO allows processes
to have characterizing attributes, whereas the BFO does
not [38]. The RO was initially [39] comprised of a collec-
tion of 8 domain-independent (e.g. has part) relations
which has since been expanded to 160 relations, although
these do not include all relations used in all OBO ontol-
ogies. OBO Foundry’s approach to building an interoper-
able set of ontologies can be contrasted with that of SIO,
where instead of coordinating needs and duplication
across dozens of ontologies, SIO serves as a single point
of interoperability capable of addressing needs that go
beyond its current scope. In order to foster semantic inter-
operability between SIO and BFO + RO, we have mapped
9 BFO classes and 24 RO relations to SIO (mapping avail-
able at [40]).
BioTop [41] is an upper level ontology for biology
and medicine that features 390 classes and 82 object
properties. The class top-level is characterized by
a flattened set of basic categories (material object,Figure 13 The assertion portion of a nanopublication that uses SIO to
Seckel Syndrome, along with its probability-value.immaterial object, information object, process, quality,
role, condition, disposition, time, value region) while
the object hierarchy provides type-specific relations
around physical, processual and abstract nature (e.g.
has physical part, has processual part, has abstract part).
BioTop includes relatively sophisticated formalization for
selected terms, for example pathological disposition is
defined as "disposition that ('inheres in' some ('bearer of'
some (canonicity and ('quality located' some 'noncanonical
value region'))))", where SIO would simply express it as a
'biological disposition' that ('is attribute of' some ('en-
tity' that 'has attribute' some 'pathological quality')).
BioTop has been used to provide a number of ontol-
ogy design patterns [42,43] and to identify semantic type
errors in the UMLS network [44].
The Translational Medicine Ontology (TMO) is a uni-
fying ontology for chemical, genomic and proteomic
data with disease, treatment, and electronic health records
[13]. The TMO acted as a central schema that mapped
basic types to dozens of bio-ontologies and linked
open data. The utility of the TMO was demonstrated
by answering a series of questions pertaining to diagnosis,
prescription, drug mechanism of action, alternativeexpress a text-mined association between the CENPJ gene and
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considerations in the TMO effort, SIO can be seen as the
supported successor to TMO.
Conclusion
The Semanticscience Integrated Ontology (SIO) is an
ontology of basic types and relations to capture a wide
span of knowledge through a set of emerging domain-
specific patterns using RDF/OWL. SIO has emerged to
support the demands of the bioinformatics community,
with a special emphasis on biological knowledge represen-
tation as well as ontology, data and service interoperability.
Availability
The SIO homepage is http://sio.semanticscience.org. SIO is
freely available under a Creative Commons by Attribution
license at http://semanticscience.org/ontology/sio.owl. Ver-
sion 1.0 of SIO is available as Additional file 1. The base
namespace for SIO entities (classes, properties) is http://
semanticscience.org/resource/. SIO entities are identified
using resolvable HTTP URIs, initially formulated as an
alphanumeric identifier e.g. http://semanticscience.org/
resource/SIO_000001, but is alternatively accessible
using a label-based identifier e.g. http://semanticscience.
org/resource/is-related-to. These and other generated
subsets are available from http://goo.gl/0LgN8.
Additional file
Additional file 1: The Semanticscience Integrated Ontology, v1.0.
This file in the format of OWL2, the Web Ontology Language.
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